Meridian Bioscience, Inc. operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Meridian Bioscience with three other
companies in this sector in the United States:
Trinity Biotech PLC
sales of $99.61 million
of which 74%
was Clinical Laboratory),
of which 100%
was Diagnostic Products), and
of which 55%
was Animal Safety).
Meridian Bioscience reported sales of $196.08 million
September of 2016.
a very small
increase of 0.6%
versus 2015, when the company's sales were $194.83 million.
Sales at Meridian Bioscience have increased during each of the previous five years
(and since 2011, sales have increased a total of 23%).
Sales of Life Sciences saw an increase
that was more than double the company's growth rate: sales were up
4.6% in 2016, from
$48.72 million to $50.97 million.
Not all segments of Meridian Bioscience experienced an increase in sales in 2016:
sales of Us Diagnostics fell 0.7% to $145.11 million.